David Rekhtman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David Rekhtman has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Amit Iyengar
Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
17 shared publications- Cindy Song
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
14 shared publications Marisa Cevasco
Division of Cardiovascular Surgery Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA
11 shared publicationsMax Shin
Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
11 shared publications- Noah Weingarten
Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
11 shared publications - Marisa Cevasco
Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
8 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Vol. 40 (3) , e70452
Impact of Prolonged Impella 5.5 Support on Post-Transplant Outcomes: An Institutional Study.
Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post-transplant outcomes. This study aims to compare post-transplantation outcomes based on duration of support with the Impella 5.5. All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1-year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year. Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1-year survival was 96% and similar between the two cohorts (p = 0.289). Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post-transplant outcomes for patients stratified by support duration.
- 1 March 2026
- Vol. 40 (3) , e70452
Open AccessImpact of Prolonged Impella 5.5 Support on Post-Transplant Outcomes: An Institutional Study.
Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post-transplant outcomes. This study aims to compare post-transplantation outcomes based on duration of support with the Impella 5.5. All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1-year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year. Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1-year survival was 96% and similar between the two cohorts (p = 0.289). Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post-transplant outcomes for patients stratified by support duration.
- Open Access
- 25 February 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (3) , e70452
Impact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study
Objectives: Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post‐transplant outcomes. This study aims to compare post‐transplantation outcomes based on duration of support with the Impella 5.5. Methods: All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1‐year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year. Results: Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1‐year survival was 96% and similar between the two cohorts ( p = 0.289). Conclusions: Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post‐transplant outcomes for patients stratified by support duration.
- 25 February 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (3) , e70452
Open AccessImpact of Prolonged Impella 5.5 Support on Post‐Transplant Outcomes: An Institutional Study
Objectives: Microaxial flow pump devices are utilized as a bridge to heart transplantation for patients in advanced cardiogenic shock. Little is known about the impact of device duration on post‐transplant outcomes. This study aims to compare post‐transplantation outcomes based on duration of support with the Impella 5.5. Methods: All patients who were successfully bridged to transplant on the Impella 5.5 platform were included and stratified based on support duration (≤ 14 days vs. > 14 days). Baseline clinical characteristics were collected throughout the index admission. Outcomes included 1‐year mortality, complications during the index admission, graft rejection, and rehospitalization within the first year. Results: Of the 72 patients successfully bridged to transplant, 64% (n = 46) were supported for more than 14 days. When stratified by duration of Impella 5.5 use, there were no differences in pretransplantation clinical status. Length of stay (26 vs. 20 days, p = 0.316) and rates of home discharges (65% vs. 67%, p = 0.524) were similar. Despite a high prevalence of rehospitalization at 1 year (75%), the 1‐year survival was 96% and similar between the two cohorts ( p = 0.289). Conclusions: Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post‐transplant outcomes for patients stratified by support duration.
- Open Access
- 25 February 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (3) , 942-944
Postoperative Hyponatremia After Pleural Symphysis
- 25 February 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 4 (3) , 942-944
Open AccessPostoperative Hyponatremia After Pleural Symphysis
- Open Access
- 20 January 2026
- Published by Ubiquity Press, Ltd. in Perspectives on Medical Education
- Vol. 15 (1) , 748-758
Beyond Online Course Evaluations: Student-Led Focus Groups for Curricular Feedback
Purpose: Medical student curricular evaluation is both beneficial and required. Most medical schools rely on online questionnaires for evaluations, but these are often overlooked or completed haphazardly. We describe the implementation of focus groups as a supplemental form of curricular assessment and evaluate students’ and faculty members’ attitudes towards this novel approach.Method: Ten randomly selected students were assigned to eight focus groups regarding three different preclerkship courses. Following the completion of focus groups, interviews were conducted with students who participated in them, course directors who received the focus group reports, and administrators who oversaw the preclerkship curriculum and the implementation of the focus group program. The semi-structured interviews were then analyzed using inductive thematic analysis, with initial codes generated from the data and subsequent interpretation informed by prior literature on feedback relationships and curricular program evaluation.Results: Interviews were conducted with 17 students, 5 faculty members, and 3 administrators. Participants highlighted key themes related to trust, engagement, collaboration, and the learning environment. Students described the focus groups as a safe space and said they enjoyed thinking critically about improvements. Faculty perceived the thematic content of focus group reports to be comparable to course evaluation summaries from established online forms despite concerns for a smaller sample size.Conclusions: Focus groups are a novel supplemental tool that can complement existing evaluation mechanisms. Engaging students through focus groups can improve feedback and advance medical school curricula, resulting in a more responsive and adaptive approach to education.
- 20 January 2026
- Published by Ubiquity Press, Ltd. in Perspectives on Medical Education
- Vol. 15 (1) , 748-758
Open AccessBeyond Online Course Evaluations: Student-Led Focus Groups for Curricular Feedback
Purpose: Medical student curricular evaluation is both beneficial and required. Most medical schools rely on online questionnaires for evaluations, but these are often overlooked or completed haphazardly. We describe the implementation of focus groups as a supplemental form of curricular assessment and evaluate students’ and faculty members’ attitudes towards this novel approach.Method: Ten randomly selected students were assigned to eight focus groups regarding three different preclerkship courses. Following the completion of focus groups, interviews were conducted with students who participated in them, course directors who received the focus group reports, and administrators who oversaw the preclerkship curriculum and the implementation of the focus group program. The semi-structured interviews were then analyzed using inductive thematic analysis, with initial codes generated from the data and subsequent interpretation informed by prior literature on feedback relationships and curricular program evaluation.Results: Interviews were conducted with 17 students, 5 faculty members, and 3 administrators. Participants highlighted key themes related to trust, engagement, collaboration, and the learning environment. Students described the focus groups as a safe space and said they enjoyed thinking critically about improvements. Faculty perceived the thematic content of focus group reports to be comparable to course evaluation summaries from established online forms despite concerns for a smaller sample size.Conclusions: Focus groups are a novel supplemental tool that can complement existing evaluation mechanisms. Engaging students through focus groups can improve feedback and advance medical school curricula, resulting in a more responsive and adaptive approach to education.
- Open Access
Impella 5.5 use in women: A multicenter study
- 2 July 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (6) , 861-863
Prolonged Impella 5.5 Support in a Pediatric Patient With Genetic Cardiomyopathy
Temporary mechanical circulatory support (tMCS) has been utilized as a bridge to heart transplantation with increasing duration of support. We describe the clinical course of a 14-year-old patient, with TNNT2 and KCNQ1 mutations, requiring Impella 5.5 support for 76 days. We discuss the patient's underlying genetic etiology, potential complications of prolonged tMCS, and the importance of multidisciplinary support. To our knowledge, this is the first published case in which a patient has this specific combination of genetic mutations and the longest published support duration of an Impella 5.5 in a pediatric patient.
- 2 July 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 16 (6) , 861-863
Prolonged Impella 5.5 Support in a Pediatric Patient With Genetic Cardiomyopathy
Temporary mechanical circulatory support (tMCS) has been utilized as a bridge to heart transplantation with increasing duration of support. We describe the clinical course of a 14-year-old patient, with TNNT2 and KCNQ1 mutations, requiring Impella 5.5 support for 76 days. We discuss the patient's underlying genetic etiology, potential complications of prolonged tMCS, and the importance of multidisciplinary support. To our knowledge, this is the first published case in which a patient has this specific combination of genetic mutations and the longest published support duration of an Impella 5.5 in a pediatric patient.
- 16 June 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (8) , 102495
Superior Waitlist Outcomes Among Patients Listed for Donation After Circulatory Death Heart Transplantation
- 16 June 2025
- Published by Elsevier in JACC: Heart Failure
- Vol. 13 (8) , 102495
Superior Waitlist Outcomes Among Patients Listed for Donation After Circulatory Death Heart Transplantation
- 17 April 2025
- Published by Wolters Kluwer Health in ASAIO Journal
Acute Hemodynamic and Echocardiographic Consequences of Impella 5.5 Placement in Patients With Advanced Cardiogenic Shock
We sought to investigate the hemodynamic and echocardiographic consequences of the Impella 5.5 during the acute perioperative period. A retrospective analysis of patients who underwent device implantation at our institution between January 2021 and June 2023 was performed. Hemodynamic and echocardiographic changes were modeled as linear mixed models with random intercepts for patient and fixed as well as random effects of time. Of 87 patients identified, most were male (72, 83%) with nonischemic cardiomyopathy (44, 51%). In the first two postoperative days, the median cardiac output increased by 1.2 L/min (p < 0.05), although the median Impella flow remained at 4.1 L/min. Mean pulmonary artery pressures (32 vs. 27 mm Hg, p < 0.05) and vasoactive inotrope scores (5.6 vs. 3.7, p < 0.01) were modestly reduced. Significant echocardiographic improvement was noted in 61% and 71% of patients with significant preoperative mitral or tricuspid regurgitation, respectively. However, no changes in ejection fraction, left ventricle (LV) diameter, or right ventricular function were noted (all p > 0.05). At 30 days, 27 (31%) patients were transplanted and 13 (15%) were bridged to a durable left ventricular assist device (LVAD). We conclude that in the acute phase following Impella implantation, LV offloading, reductions in pulmonary artery pressures, and improvement in valvular regurgitation are seen without changes to ventricular geometry.
- 17 April 2025
- Published by Wolters Kluwer Health in ASAIO Journal
Acute Hemodynamic and Echocardiographic Consequences of Impella 5.5 Placement in Patients With Advanced Cardiogenic Shock
We sought to investigate the hemodynamic and echocardiographic consequences of the Impella 5.5 during the acute perioperative period. A retrospective analysis of patients who underwent device implantation at our institution between January 2021 and June 2023 was performed. Hemodynamic and echocardiographic changes were modeled as linear mixed models with random intercepts for patient and fixed as well as random effects of time. Of 87 patients identified, most were male (72, 83%) with nonischemic cardiomyopathy (44, 51%). In the first two postoperative days, the median cardiac output increased by 1.2 L/min (p < 0.05), although the median Impella flow remained at 4.1 L/min. Mean pulmonary artery pressures (32 vs. 27 mm Hg, p < 0.05) and vasoactive inotrope scores (5.6 vs. 3.7, p < 0.01) were modestly reduced. Significant echocardiographic improvement was noted in 61% and 71% of patients with significant preoperative mitral or tricuspid regurgitation, respectively. However, no changes in ejection fraction, left ventricle (LV) diameter, or right ventricular function were noted (all p > 0.05). At 30 days, 27 (31%) patients were transplanted and 13 (15%) were bridged to a durable left ventricular assist device (LVAD). We conclude that in the acute phase following Impella implantation, LV offloading, reductions in pulmonary artery pressures, and improvement in valvular regurgitation are seen without changes to ventricular geometry.
- Open Access
Epidemiology and impact of device-specific infections on patients receiving left ventricular assist devices